Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ro 40-7592, a novel, very potent, and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats.

× No keyword cloud information.

18 in total

1. Effects of tolcapone, a catechol-O-methyltransferase inhibitor, on motor symptoms and pharmacokinetics of levodopa in patients with Parkinson's disease.

Authors: M Yamamoto; M Yokochi; S Kuno; Y Hattori; Y Tsukamoto; H Narabayashi; H Tohgi; Y Mizuno; H Kowa; N Yanagisawa; I Kanazawa
Journal: J Neural Transm (Vienna) Date: 1997 Impact factor: 3.575

2. Cognitive improvement during Tolcapone treatment in Parkinson's disease.

Authors: M Gasparini; E Fabrizio; V Bonifati; G Meco
Journal: J Neural Transm (Vienna) Date: 1997 Impact factor: 3.575

Review 3. Targeting Metalloenzymes for Therapeutic Intervention.

Authors: Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal: Chem Rev Date: 2018-09-07 Impact factor: 60.622

Review 4. Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors: José A Apud; Daniel R Weinberger
Journal: CNS Drugs Date: 2007 Impact factor: 5.749

5. Clinical Potential of Catechol-OMethyltransferase (COMT) Inhibitors as Adjuvants in Parkinson's Disease.

Authors: P T Ménnistó
Journal: CNS Drugs Date: 1994-03 Impact factor: 5.749

6. Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form.

Authors: B Bertocci; V Miggiano; M Da Prada; Z Dembic; H W Lahm; P Malherbe
Journal: Proc Natl Acad Sci U S A Date: 1991-02-15 Impact factor: 11.205

7. Ontogenic aspects of liver and kidney catechol-O-methyltransferase sensitivity to tolcapone.

Authors: M A Vieira-Coelho; P Soares-da-Silva
Journal: Br J Pharmacol Date: 1996-02 Impact factor: 8.739

Review 8. Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition.

Authors: M B Youdim; P Riederer
Journal: J Neural Transm Gen Sect Date: 1993

Review 9. Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?

Authors: T Müller; W Kuhn; H Przuntek
Journal: J Neural Transm Gen Sect Date: 1993

10. Regional brain kinetics of 6-fluoro-(beta-11C)-L-dopa and (beta-11C)-L-dopa following COMT inhibition. A study in vivo using positron emission tomography.

Authors: P Hartvig; K J Lindner; J Tedroff; P Bjurling; K Hörnfelt; B Långström
Journal: J Neural Transm Gen Sect Date: 1992